Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nagy

Showing results (361-370 of 395) with videos related to

Pageof 40
Sort By:
JCO Precision Oncology|September 11, 2019
Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in <i>BRCA2</i>-Associated Prostate Cancer Resulting From Biallelic <i>BRCA2</i> Reversion Mutations Restores Both Germline and Somatic Loss-of-Function MutationsB A Carneiro, K A Collier, R J Nagy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2018
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer PatientsOliver A Zill, Kimberly C Banks, Stephen R Fairclough, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2018
Combined Blockade of Activating <i>ERBB2</i> Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast CancerSarah Croessmann, Luigi Formisano, Lisa N Kinch, et al.
European Urology Oncology|August 15, 2019
Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot StudyPetros Grivas, Aly-Khan A Lalani, Gregory R Pond, et al.
Translational Psychiatry|July 26, 2017
Altered neurite morphology and cholinergic function of induced pluripotent stem cell-derived neurons from a patient with Kleefstra syndrome and autismJ Nagy, J Kobolák, S Berzsenyi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2019
Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10Jame Abraham, Albert J Montero, Rachel C Jankowitz, et al.
Cancer Discovery|December 3, 2017
Genomic Landscape of Cell-Free DNA in Patients with Colorectal CancerJohn H Strickler, Jonathan M Loree, Leanne G Ahronian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2018
Anaplastic Lymphoma Kinase Mutation (<i>ALK</i> F1174C) in Small Cell Carcinoma of the Prostate and Molecular Response to AlectinibBenedito A Carneiro, Sahithi Pamarthy, Ami N Shah, et al.
Orvosi Hetilap|June 23, 2001
[Analgesics-induced chronic renal failure in patients on dialysis therapy in Hungary]I Pintér, J Mátyus, Z Czégány, et al.
Cancer|January 9, 2019
Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancerGuru Sonpavde, Neeraj Agarwal, Gregory Russell Pond, et al.
Pageof 40

Showing results (361-370 of 395) with videos related to

Sort By:
Pageof 40
JCO Precision Oncology|September 11, 2019
Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in <i>BRCA2</i>-Associated Prostate Cancer Resulting From Biallelic <i>BRCA2</i> Reversion Mutations Restores Both Germline and Somatic Loss-of-Function MutationsB A Carneiro, K A Collier, R J Nagy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2018
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer PatientsOliver A Zill, Kimberly C Banks, Stephen R Fairclough, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2018
Combined Blockade of Activating <i>ERBB2</i> Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast CancerSarah Croessmann, Luigi Formisano, Lisa N Kinch, et al.
European Urology Oncology|August 15, 2019
Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot StudyPetros Grivas, Aly-Khan A Lalani, Gregory R Pond, et al.
Translational Psychiatry|July 26, 2017
Altered neurite morphology and cholinergic function of induced pluripotent stem cell-derived neurons from a patient with Kleefstra syndrome and autismJ Nagy, J Kobolák, S Berzsenyi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2019
Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10Jame Abraham, Albert J Montero, Rachel C Jankowitz, et al.
Cancer Discovery|December 3, 2017
Genomic Landscape of Cell-Free DNA in Patients with Colorectal CancerJohn H Strickler, Jonathan M Loree, Leanne G Ahronian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2018
Anaplastic Lymphoma Kinase Mutation (<i>ALK</i> F1174C) in Small Cell Carcinoma of the Prostate and Molecular Response to AlectinibBenedito A Carneiro, Sahithi Pamarthy, Ami N Shah, et al.
Orvosi Hetilap|June 23, 2001
[Analgesics-induced chronic renal failure in patients on dialysis therapy in Hungary]I Pintér, J Mátyus, Z Czégány, et al.
Cancer|January 9, 2019
Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancerGuru Sonpavde, Neeraj Agarwal, Gregory Russell Pond, et al.
Pageof 40